however, there is no direct clinical evidence yet linking cagrilintide or retatrutide specifically to improvements in erectile function
In one single-center trial of 72 subjects using a controlled-adverse-environment model, the T4 eye drop did not meet its co-primary endpoints (ocular discomfort and inferior corneal staining) at the primary time point, but it did produce statistically significant improvements on several secondary endpoints, including central and superior corneal staining, with no adverse events reported
"It's crucial to allow patients to have safe and effective access to these treatment options," Buhler said
Combine with activity modification and eccentric exercise rehabilitation
It can range from mild queasiness to severe discomfort
The drug binds to GLP-1 receptors across multiple organ systems, triggering a coordinated response that attacks weight gain from several directions simultaneously